When I was first diagnosed with breast cancer and discussing chemotherapy with my first oncologist (yeah, I’ve had five, but who’s counting?), we talked about the Oncotype DX® Test. This test helps determine risk for distant recurrence in some early-stage, estrogen-positive breast cancers. It is used to help decide if a patient will benefit from …
Aromatase inhibitors
As I mentioned in my previous post, I have passed the five-year mark of being on an aromatase inhibitor. So now what? I have decided I am going to stay on Aromasin. I do not know how long I will stay on it, but I am going to hang in there for a while longer. …
I have written several times about the dreaded aromatase inhibitors, or as many of us prefer to call them, the drugs we love to hate. Those posts are among my most-read and most-commented-on posts. Plus, I get emails regularly from women who are sharing about their struggles and frustrations with these drugs. So yes, it’s …
I receive requests quite often to review products and books. Generally, I say thanks, but no thanks. Frankly, I get tired of being asked to provide free advertising via my blog. I value you, your time, my time and the integrity of content I write too much to do that, and so I don’t say …
There is that certain “f” word we all know about. There are one or two others as well. In Cancerland, another “f” word is fatigue because cancer is exhausting in oh-so-many ways not only for the patient, but for the caregiver(s) too. But I’m not talking about either of those words. I’m talking about yet …